Three months after remission, she developed stiffness in the contralateral breast, and biopsy revealed grade 3 invasive ductal carcinoma that was estrogen receptor (ER)-positive, progesterone receptor (PR)-negative, and HER2 (1+). This evidence concerns the gene ESR1 and invasive ductal breast carcinoma.